Strong performance drives investor interest
Matthias Goegele, Head of Multi-Managers Private Equity Europe
Over the past 12 to 18 months, private equity has continued to attract strong inflows both globally and across various investment strategies. Against a backdrop of generally robust macro-economic conditions and a strongly performing public equities market, this has been driven by investor appetite for strong risk-adjusted returns.
2017 private equity industry review
In North America, buyout activities for 2017 amounted to USD 421 billion, representing an increase of 12% compared to 2016. 2017 was also another strong year for European buyouts—one of the highest years on record, partially driven by cross-border deals completed by non-European investors. Exits in Europe followed the same trend as seen in North America, with 2017 volume declining slightly from 1,570 deals in 2016 to 1,544. Fundraising also experienced a slight dip—88 funds closed at an aggregate value of USD 69 billion. Buyouts in Asia increased in 2017 and venture capital activity in Asia remained robust with a larger total value of USD 82 billion.1
Trend to watch—private equity and healthcare
The healthcare sector has attracted increased interest from private equity investors. In an environment which is generally impacted by political and macro-economic uncertainties, powerful secular and demographic trends provide the basis for robust long-term growth dynamics that are mostly resilient through economic cycles.
A continuing global environment of high public market valuations will be a cause for concern as private equity players fret over the availability of upside and the pressure it puts on private market valuations. Undoubtedly, the equity bull market that started 2018 has been partly fueled by the quantitative easing that has been ongoing in much of the world, not least in China. It looks likely that this monetary policy support will diminish in the coming year, albeit gradually. Meanwhile, uncertainty around global trade, brought on by the targeted US tariffs on specific goods or industries as well as the US cancelation of its nuclear deal with Iran, is likely to persist.
Where does this leave private equity?
While increased prudence and additional caution is advised, we do not think investor interest in private equity will drop off significantly. We remain convicted that our investment focus on the global growth themes, including small- and medium-sized buyouts, is better positioned to reap the upside of a continued growth scenario.
The website contains general information about UBS Asset Management (Americas), Inc., UBS Hedge Fund Solutions LLC, and UBS O'Connor LLC, collectively known as "UBS Asset Management". The information contained on this website does not constitute investment advice or a recommendation to purchase or sell any securities or other financial instrument or any particular strategy or fund. Market commentary, product information and related performance data available on this website has been compiled from sources believed to be reliable and is provided in good faith for informational purposes only. UBS Asset Management does not guarantee the accuracy, suitability or completeness of information contained on this website, and all such information, including but not limited to performance data and related metrics, is subject to change without notice. Certain content on this website is intended for institutional investors and their financial representatives only, and should not be relied upon by retail investors or members of the general public.
Market commentary and similar statements contained herein are based on current expectations and may be considered “forward-looking statements.” Actual future results, however, may prove to be different from expectations. The opinions expressed are a reflection of UBS Asset Management’s best judgment at the time of posting, and any obligation to update or alter any forward-looking statement as a result of new information, future events, or otherwise is disclaimed.
Investments involve risks, are not guaranteed and may not return the original principal amount invested. Past performance is no guarantee of future results. Investors should read all available product information carefully before making an investment decision, including information about applicable risks, fees and expenses. This website does not address the investment objectives, risk tolerance or financial needs of any particular investor. In addition, any statements regarding investment performance expectations, risk and/or return targets do not constitute a representation or warranty that such expectations or targets will be achieved.
This website is not intended for persons located in any jurisdiction where the availability of this website is prohibited or contrary to local law or regulation or would subject any UBS entity to any registration or licensing requirement in any such jurisdiction.
Please confirm you are a US resident to proceed.